FierceBiotechFierceBiotechResearchFierceBiotechITFierceVaccinesFiercePharmaFiercePharmaManufacturing   FierceHealthcare

Free Newsletter

About | View Sample | Privacy
Related Topics >> Duragesic

Another company recalls fentaynl patch


Free newsletter via e-mail
Tools

Different manufacturer, same problem. Another company is recalling painkiller patches because of a flaw that could cause patients or caregivers to overdose on the fentanyl drug inside.

The new recall covers 14 lots of patches sold by Actavis; they have that company's name and its former name, Abrika Pharmaceuticals, on their packaging. Actavis said its patches have a "foldover defect" that might cause leaks. Last week, PriCara, a division of Johnson & Johnson withdrew batches of its Duragesic fentanyl patches. In the latter case, some of the patches had slits in the drug reservoir, leaking fentanyl into the packaging.

Quite a coincidence. Or did the news of J&J's recall alert Actavis to the possibility of a design flaw in its own product?

- see Actavis' release
- see the news in the Washington Post

Related Article:
Millions of fentanyl patches recalled. Report


SHARE
WITH:
Email Twitter Facebook LinkedIn StumbleUpon
Get Your FREE FiercePharma Email Newsletter:
Be the first to comment
More stories about Duragesic  

Comments

Post new comment

The content of this field is kept private and will not be shown publicly.

More information about formatting options

To combat spam, please enter the code in the image.